锦欣生殖12月11日斥资954.21万港元回购384.6万股
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 11, 2025, involving an expenditure of HKD 9.5421 million to repurchase 3.846 million shares [1]
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 11, 2025, involving an expenditure of HKD 9.5421 million to repurchase 3.846 million shares [1]